Kraematon Investment Advisors Inc. Has $219,000 Stock Holdings in Healthpeak Properties, Inc. $DOC

Kraematon Investment Advisors Inc. trimmed its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 5.1% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 12,524 shares of the real estate investment trust’s stock after selling 674 shares during the quarter. Kraematon Investment Advisors Inc.’s holdings in Healthpeak Properties were worth $219,000 as of its most recent filing with the SEC.

Other large investors have also bought and sold shares of the company. Machina Capital S.A.S. increased its stake in Healthpeak Properties by 62.8% during the 1st quarter. Machina Capital S.A.S. now owns 37,160 shares of the real estate investment trust’s stock worth $751,000 after purchasing an additional 14,336 shares in the last quarter. Cambridge Investment Research Advisors Inc. grew its position in Healthpeak Properties by 6.9% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 357,520 shares of the real estate investment trust’s stock valued at $7,229,000 after purchasing an additional 23,135 shares in the last quarter. Ibex Wealth Advisors acquired a new stake in Healthpeak Properties in the 1st quarter valued at $5,056,000. Vert Asset Management LLC lifted its position in Healthpeak Properties by 6.9% during the 1st quarter. Vert Asset Management LLC now owns 325,143 shares of the real estate investment trust’s stock worth $6,574,000 after buying an additional 20,924 shares in the last quarter. Finally, Deutsche Bank AG boosted its stake in shares of Healthpeak Properties by 0.3% during the 1st quarter. Deutsche Bank AG now owns 8,482,898 shares of the real estate investment trust’s stock worth $171,524,000 after buying an additional 23,136 shares during the last quarter. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Trading Up 1.1%

Shares of Healthpeak Properties stock opened at $19.39 on Friday. Healthpeak Properties, Inc. has a 1 year low of $16.63 and a 1 year high of $23.26. The company has a market capitalization of $13.47 billion, a price-to-earnings ratio of 80.77, a P/E/G ratio of 2.50 and a beta of 1.09. The business has a fifty day simple moving average of $17.86 and a two-hundred day simple moving average of $18.01. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. The company had revenue of $694.35 million for the quarter, compared to analyst estimates of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The company’s revenue was down .2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Research analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a monthly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 18th were issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 6.3%. The ex-dividend date was Monday, August 18th. Healthpeak Properties’s payout ratio is currently 508.33%.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Evercore ISI set a $22.00 target price on Healthpeak Properties in a research report on Monday, September 15th. Raymond James Financial upgraded Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a research note on Monday, September 15th. Morgan Stanley decreased their target price on shares of Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating for the company in a research note on Friday, August 22nd. Wall Street Zen cut shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Monday, July 7th. Finally, Wells Fargo & Company decreased their target price on shares of Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 27th. Eight equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Healthpeak Properties presently has a consensus rating of “Moderate Buy” and an average price target of $21.33.

Insider Activity at Healthpeak Properties

In other news, CEO Scott M. Brinker bought 2,930 shares of the stock in a transaction dated Thursday, July 31st. The shares were bought at an average price of $17.06 per share, for a total transaction of $49,985.80. Following the completion of the purchase, the chief executive officer owned 210,416 shares in the company, valued at approximately $3,589,696.96. This trade represents a 1.41% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders purchased a total of 8,783 shares of company stock valued at $150,129 over the last 90 days. 0.23% of the stock is currently owned by corporate insiders.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.